APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prevent Meningitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Prevent Meningitis Vaccine Industry Research Report 2026

Report ID 174028390529 December 2025130 pages

Choose your research edition.

Industry ResearchPrevent Meningitis Vaccine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prevent Meningitis Vaccine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prevent Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prevent Meningitis Vaccine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Prevent Meningitis Vaccine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Prevent Meningitis Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Prevent Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Prevent Meningitis Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Prevent Meningitis Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Prevent Meningitis Vaccine include GSK, China National Biotec Group, Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Tianjin CanSino Biotechnology, Pfizer and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Prevent Meningitis Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Prevent Meningitis Vaccine Market by Company

GSK

China National Biotec Group

Zhejiang Tianyuan

Sanofi Pasteur

Novartis

Merck

Tianjin CanSino Biotechnology

Pfizer

Hualan Bio

Beijing Tiantan Biological

Baxter International

Zhifei

Wyeth Pharmaceuticals, Inc

Walvax

Serum Institute of India

JN International Medical Corporation

CSL Behring

Bio-Med

Prevent Meningitis Vaccine Segment by Type

Meningococcal AC Vaccine

Meningococcal A Vaccine

Meningococcal B Vaccine (MenB)

Meningococcal Conjugate Vaccine (MenaCWY)

Prevent Meningitis Vaccine Segment by Application

Baby

Teenager

Child

Others

Prevent Meningitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prevent Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prevent Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prevent Meningitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Prevent Meningitis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Prevent Meningitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Prevent Meningitis Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Prevent Meningitis Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Prevent Meningitis Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Prevent Meningitis Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Prevent Meningitis Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Prevent Meningitis Vaccine, Product Type & Application Table 14. Global Prevent Meningitis Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Prevent Meningitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GSK Company Information Table 19. GSK Business Overview Table 20. GSK Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. GSK Prevent Meningitis Vaccine Product Portfolio Table 22. GSK Recent Developments Table 23. China National Biotec Group Company Information Table 24. China National Biotec Group Business Overview Table 25. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. China National Biotec Group Prevent Meningitis Vaccine Product Portfolio Table 27. China National Biotec Group Recent Developments Table 28. Zhejiang Tianyuan Company Information Table 29. Zhejiang Tianyuan Business Overview Table 30. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio Table 32. Zhejiang Tianyuan Recent Developments Table 33. Sanofi Pasteur Company Information Table 34. Sanofi Pasteur Business Overview Table 35. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio Table 37. Sanofi Pasteur Recent Developments Table 38. Novartis Company Information Table 39. Novartis Business Overview Table 40. Novartis Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Novartis Prevent Meningitis Vaccine Product Portfolio Table 42. Novartis Recent Developments Table 43. Merck Company Information Table 44. Merck Business Overview Table 45. Merck Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Merck Prevent Meningitis Vaccine Product Portfolio Table 47. Merck Recent Developments Table 48. Tianjin CanSino Biotechnology Company Information Table 49. Tianjin CanSino Biotechnology Business Overview Table 50. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio Table 52. Tianjin CanSino Biotechnology Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pfizer Prevent Meningitis Vaccine Product Portfolio Table 57. Pfizer Recent Developments Table 58. Hualan Bio Company Information Table 59. Hualan Bio Business Overview Table 60. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hualan Bio Prevent Meningitis Vaccine Product Portfolio Table 62. Hualan Bio Recent Developments Table 63. Beijing Tiantan Biological Company Information Table 64. Beijing Tiantan Biological Business Overview Table 65. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio Table 67. Beijing Tiantan Biological Recent Developments Table 68. Baxter International Company Information Table 69. Baxter International Business Overview Table 70. Baxter International Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Baxter International Prevent Meningitis Vaccine Product Portfolio Table 72. Baxter International Recent Developments Table 73. Zhifei Company Information Table 74. Zhifei Business Overview Table 75. Zhifei Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zhifei Prevent Meningitis Vaccine Product Portfolio Table 77. Zhifei Recent Developments Table 78. Wyeth Pharmaceuticals, Inc Company Information Table 79. Wyeth Pharmaceuticals, Inc Business Overview Table 80. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio Table 82. Wyeth Pharmaceuticals, Inc Recent Developments Table 83. Walvax Company Information Table 84. Walvax Business Overview Table 85. Walvax Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Walvax Prevent Meningitis Vaccine Product Portfolio Table 87. Walvax Recent Developments Table 88. Serum Institute of India Company Information Table 89. Serum Institute of India Business Overview Table 90. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Serum Institute of India Prevent Meningitis Vaccine Product Portfolio Table 92. Serum Institute of India Recent Developments Table 93. JN International Medical Corporation Company Information Table 94. JN International Medical Corporation Business Overview Table 95. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio Table 97. JN International Medical Corporation Recent Developments Table 98. CSL Behring Company Information Table 99. CSL Behring Business Overview Table 100. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CSL Behring Prevent Meningitis Vaccine Product Portfolio Table 102. CSL Behring Recent Developments Table 103. Bio-Med Company Information Table 104. Bio-Med Business Overview Table 105. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bio-Med Prevent Meningitis Vaccine Product Portfolio Table 107. Bio-Med Recent Developments Table 108. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Prevent Meningitis Vaccine Sales by Region (2021-2026) & (K Units) Table 110. Global Prevent Meningitis Vaccine Sales Market Share by Region (2021-2026) Table 111. Global Prevent Meningitis Vaccine Sales by Region (2027-2032) & (K Units) Table 112. Global Prevent Meningitis Vaccine Sales Market Share by Region (2027-2032) Table 113. Global Prevent Meningitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2021-2026) Table 115. Global Prevent Meningitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2027-2032) Table 117. North America Prevent Meningitis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 119. North America Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 120. North America Prevent Meningitis Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Prevent Meningitis Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Prevent Meningitis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 124. Europe Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 125. Europe Prevent Meningitis Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Prevent Meningitis Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Prevent Meningitis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Prevent Meningitis Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Prevent Meningitis Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Prevent Meningitis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 134. South America Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 135. South America Prevent Meningitis Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Prevent Meningitis Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 143. Global Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 144. Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2026) Table 145. Global Prevent Meningitis Vaccine Sales Market Share by Type (2027-2032) Table 146. Global Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2026) Table 149. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2027-2032) Table 150. Global Prevent Meningitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 151. Global Prevent Meningitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 152. Global Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 153. Global Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 154. Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2026) Table 155. Global Prevent Meningitis Vaccine Sales Market Share by Application (2027-2032) Table 156. Global Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2026) Table 159. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2027-2032) Table 160. Global Prevent Meningitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 161. Global Prevent Meningitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Prevent Meningitis Vaccine Distributors List Table 165. Prevent Meningitis Vaccine Customers List Table 166. Prevent Meningitis Vaccine Industry Trends Table 167. Prevent Meningitis Vaccine Industry Drivers Table 168. Prevent Meningitis Vaccine Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Prevent Meningitis Vaccine Product Image Figure 5. Global Prevent Meningitis Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Prevent Meningitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Prevent Meningitis Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Prevent Meningitis Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Meningococcal AC Vaccine Product Image Figure 10. Meningococcal A Vaccine Product Image Figure 11. Meningococcal B Vaccine (MenB) Product Image Figure 12. Meningococcal Conjugate Vaccine (MenaCWY) Product Image Figure 13. Baby Product Image Figure 14. Teenager Product Image Figure 15. Child Product Image Figure 16. Others Product Image Figure 17. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Prevent Meningitis Vaccine Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Prevent Meningitis Vaccine Sales by Region in 2025 Figure 23. Global Prevent Meningitis Vaccine Revenue by Region in 2025 Figure 24. North America Prevent Meningitis Vaccine Market Size by Country in 2025 Figure 25. North America Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 26. North America Prevent Meningitis Vaccine Revenue Market Share by Country (2021-2032) Figure 27. United States Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Prevent Meningitis Vaccine Market Size by Country in 2025 Figure 30. Europe Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 31. Europe Prevent Meningitis Vaccine Revenue Market Share by Country (2021-2032) Figure 32. Germany Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Prevent Meningitis Vaccine Market Size by Country in 2025 Figure 38. Asia Pacific Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Prevent Meningitis Vaccine Revenue Market Share by Country (2021-2032) Figure 40. China Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Prevent Meningitis Vaccine Market Size by Country in 2025 Figure 49. South America Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 50. South America Prevent Meningitis Vaccine Revenue Market Share by Country (2021-2032) Figure 51. Mexico Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Prevent Meningitis Vaccine Market Size by Country in 2025 Figure 55. Middle East and Africa Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Prevent Meningitis Vaccine Revenue Market Share by Country (2021-2032) Figure 57. Turkey Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Prevent Meningitis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2032) Figure 61. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2032) Figure 62. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2021-2032) Figure 63. Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2032) Figure 64. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2032) Figure 65. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2021-2032) Figure 66. Prevent Meningitis Vaccine Value Chain Figure 67. Prevent Meningitis Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Prevent Meningitis Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Meningococcal AC Vaccine
  • Meningococcal A Vaccine
  • Meningococcal B Vaccine (MenB)
  • Meningococcal Conjugate Vaccine (MenaCWY)
Applications
  • Baby
  • Teenager
  • Child
  • Others
Companies covered
  • GSK
  • China National Biotec Group
  • Zhejiang Tianyuan
  • Sanofi Pasteur
  • Novartis
  • Merck
  • Tianjin CanSino Biotechnology
  • Pfizer
  • Hualan Bio
  • Beijing Tiantan Biological
  • Baxter International
  • Zhifei
  • Wyeth Pharmaceuticals, Inc
  • Walvax
  • Serum Institute of India
  • JN International Medical Corporation
  • CSL Behring
  • Bio-Med

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Prevent Meningitis Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Prevent Meningitis Vaccine Sales (2021-2032)
  5. 2.2.3 Global Prevent Meningitis Vaccine Market Average Price (2021-2032)
  6. 2.3 Prevent Meningitis Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Meningococcal AC Vaccine
  9. 2.3.3 Meningococcal A Vaccine
  10. 2.3.4 Meningococcal B Vaccine (MenB)
  11. 2.3.5 Meningococcal Conjugate Vaccine (MenaCWY)
  12. 2.4 Prevent Meningitis Vaccine by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Baby
  15. 2.4.3 Teenager
  16. 2.4.4 Child
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Prevent Meningitis Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Prevent Meningitis Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Prevent Meningitis Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Prevent Meningitis Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Prevent Meningitis Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Prevent Meningitis Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Prevent Meningitis Vaccine, Established Date
  9. 3.9 Global Prevent Meningitis Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GSK
  2. 4.1.1 GSK Company Information
  3. 4.1.2 GSK Business Overview
  4. 4.1.3 GSK Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
  6. 4.1.5 GSK Recent Developments
  7. 4.2 China National Biotec Group
  8. 4.2.1 China National Biotec Group Company Information
  9. 4.2.2 China National Biotec Group Business Overview
  10. 4.2.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
  12. 4.2.5 China National Biotec Group Recent Developments
  13. 4.3 Zhejiang Tianyuan
  14. 4.3.1 Zhejiang Tianyuan Company Information
  15. 4.3.2 Zhejiang Tianyuan Business Overview
  16. 4.3.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
  18. 4.3.5 Zhejiang Tianyuan Recent Developments
  19. 4.4 Sanofi Pasteur
  20. 4.4.1 Sanofi Pasteur Company Information
  21. 4.4.2 Sanofi Pasteur Business Overview
  22. 4.4.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
  24. 4.4.5 Sanofi Pasteur Recent Developments
  25. 4.5 Novartis
  26. 4.5.1 Novartis Company Information
  27. 4.5.2 Novartis Business Overview
  28. 4.5.3 Novartis Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Novartis Prevent Meningitis Vaccine Product Portfolio
  30. 4.5.5 Novartis Recent Developments
  31. 4.6 Merck
  32. 4.6.1 Merck Company Information
  33. 4.6.2 Merck Business Overview
  34. 4.6.3 Merck Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Merck Prevent Meningitis Vaccine Product Portfolio
  36. 4.6.5 Merck Recent Developments
  37. 4.7 Tianjin CanSino Biotechnology
  38. 4.7.1 Tianjin CanSino Biotechnology Company Information
  39. 4.7.2 Tianjin CanSino Biotechnology Business Overview
  40. 4.7.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
  42. 4.7.5 Tianjin CanSino Biotechnology Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 Hualan Bio
  50. 4.9.1 Hualan Bio Company Information
  51. 4.9.2 Hualan Bio Business Overview
  52. 4.9.3 Hualan Bio Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
  54. 4.9.5 Hualan Bio Recent Developments
  55. 4.10 Beijing Tiantan Biological
  56. 4.10.1 Beijing Tiantan Biological Company Information
  57. 4.10.2 Beijing Tiantan Biological Business Overview
  58. 4.10.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
  60. 4.10.5 Beijing Tiantan Biological Recent Developments
  61. 4.11 Baxter International
  62. 4.11.1 Baxter International Company Information
  63. 4.11.2 Baxter International Business Overview
  64. 4.11.3 Baxter International Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
  66. 4.11.5 Baxter International Recent Developments
  67. 4.12 Zhifei
  68. 4.12.1 Zhifei Company Information
  69. 4.12.2 Zhifei Business Overview
  70. 4.12.3 Zhifei Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
  72. 4.12.5 Zhifei Recent Developments
  73. 4.13 Wyeth Pharmaceuticals, Inc
  74. 4.13.1 Wyeth Pharmaceuticals, Inc Company Information
  75. 4.13.2 Wyeth Pharmaceuticals, Inc Business Overview
  76. 4.13.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
  78. 4.13.5 Wyeth Pharmaceuticals, Inc Recent Developments
  79. 4.14 Walvax
  80. 4.14.1 Walvax Company Information
  81. 4.14.2 Walvax Business Overview
  82. 4.14.3 Walvax Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Walvax Prevent Meningitis Vaccine Product Portfolio
  84. 4.14.5 Walvax Recent Developments
  85. 4.15 Serum Institute of India
  86. 4.15.1 Serum Institute of India Company Information
  87. 4.15.2 Serum Institute of India Business Overview
  88. 4.15.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
  90. 4.15.5 Serum Institute of India Recent Developments
  91. 4.16 JN International Medical Corporation
  92. 4.16.1 JN International Medical Corporation Company Information
  93. 4.16.2 JN International Medical Corporation Business Overview
  94. 4.16.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
  96. 4.16.5 JN International Medical Corporation Recent Developments
  97. 4.17 CSL Behring
  98. 4.17.1 CSL Behring Company Information
  99. 4.17.2 CSL Behring Business Overview
  100. 4.17.3 CSL Behring Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
  102. 4.17.5 CSL Behring Recent Developments
  103. 4.18 Bio-Med
  104. 4.18.1 Bio-Med Company Information
  105. 4.18.2 Bio-Med Business Overview
  106. 4.18.3 Bio-Med Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
  108. 4.18.5 Bio-Med Recent Developments
5 Global Prevent Meningitis Vaccine Market Scenario by Region
  1. 5.1 Global Prevent Meningitis Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Prevent Meningitis Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Prevent Meningitis Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Prevent Meningitis Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Prevent Meningitis Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Prevent Meningitis Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Prevent Meningitis Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Prevent Meningitis Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Prevent Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Prevent Meningitis Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Prevent Meningitis Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Prevent Meningitis Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Prevent Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Prevent Meningitis Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Prevent Meningitis Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Prevent Meningitis Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Prevent Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Prevent Meningitis Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Prevent Meningitis Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Prevent Meningitis Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Prevent Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Prevent Meningitis Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Prevent Meningitis Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Prevent Meningitis Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Prevent Meningitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Prevent Meningitis Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Prevent Meningitis Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Prevent Meningitis Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Prevent Meningitis Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Prevent Meningitis Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Prevent Meningitis Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Prevent Meningitis Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Prevent Meningitis Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Prevent Meningitis Vaccine Value Chain Analysis
  2. 8.1.1 Prevent Meningitis Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Prevent Meningitis Vaccine Production Mode & Process
  5. 8.2 Prevent Meningitis Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Prevent Meningitis Vaccine Distributors
  8. 8.2.3 Prevent Meningitis Vaccine Customers
9 Global Prevent Meningitis Vaccine Analyzing Market Dynamics
  1. 9.1 Prevent Meningitis Vaccine Industry Trends
  2. 9.2 Prevent Meningitis Vaccine Industry Drivers
  3. 9.3 Prevent Meningitis Vaccine Industry Opportunities and Challenges
  4. 9.4 Prevent Meningitis Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst